Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dive

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
Acta Gastro-Enterologica Belgica|May 1, 1978
[The clinical significance of circulating immune complexes in Crohn's disease (author's transl)]R Fiasse, A Z Lurhuma, P L Masson, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2007
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasmaJ Cummings, M Ranson, F Butt, et al.
Digestive Diseases and Sciences|September 1, 1989
Changes in serum and intestinal diamine oxidase (DAO) activity after proximal enterectomy in rats. Correlation of DAO activity with mucosal mass parametersJ P Buts, S Theys, N De Keyser, et al.
European Journal of Clinical Investigation|August 1, 1974
Origin and nature of the proteins of bile. II. A comparative analysis of serum, hepatic lymph and bile proteins in the dogC Dive, R A Nadalini, J P Vaerman, et al.
British Journal of Pharmacology|September 19, 2007
Biomarker method validation in anticancer drug developmentJ Cummings, T H Ward, A Greystoke, et al.
British Journal of Cancer|September 5, 2013
The interaction between prognostic and pharmacodynamic biomarkersL Bouranis, M Sperrin, A Greystoke, et al.
Endoscopy|May 1, 1987
Hepatic ascaridiasisM van Severen, B Lengele, J Dureuil, et al.
Liver|October 1, 1988
Hypoceruloplasminemia and ultrastructural changes resembling Wilson's disease in nonalcoholic liver steatosis. A clinical and pathological study of five casesA P Geubel, V Gregoire, J Rahier, et al.
Carcinogenesis|March 14, 1998
The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and FasJ H Gill, N H James, R A Roberts, et al.
Blood|December 9, 1998
Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosisQ Chen, N Takeyama, G Brady, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
Acta Gastro-Enterologica Belgica|May 1, 1978
[The clinical significance of circulating immune complexes in Crohn's disease (author's transl)]R Fiasse, A Z Lurhuma, P L Masson, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2007
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasmaJ Cummings, M Ranson, F Butt, et al.
Digestive Diseases and Sciences|September 1, 1989
Changes in serum and intestinal diamine oxidase (DAO) activity after proximal enterectomy in rats. Correlation of DAO activity with mucosal mass parametersJ P Buts, S Theys, N De Keyser, et al.
European Journal of Clinical Investigation|August 1, 1974
Origin and nature of the proteins of bile. II. A comparative analysis of serum, hepatic lymph and bile proteins in the dogC Dive, R A Nadalini, J P Vaerman, et al.
British Journal of Pharmacology|September 19, 2007
Biomarker method validation in anticancer drug developmentJ Cummings, T H Ward, A Greystoke, et al.
British Journal of Cancer|September 5, 2013
The interaction between prognostic and pharmacodynamic biomarkersL Bouranis, M Sperrin, A Greystoke, et al.
Endoscopy|May 1, 1987
Hepatic ascaridiasisM van Severen, B Lengele, J Dureuil, et al.
Liver|October 1, 1988
Hypoceruloplasminemia and ultrastructural changes resembling Wilson's disease in nonalcoholic liver steatosis. A clinical and pathological study of five casesA P Geubel, V Gregoire, J Rahier, et al.
Carcinogenesis|March 14, 1998
The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and FasJ H Gill, N H James, R A Roberts, et al.
Blood|December 9, 1998
Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosisQ Chen, N Takeyama, G Brady, et al.
Pageof 21